Abstract
Kaposiform lymphangiomatosis (KLA), which is a new subtype of generalized lymphatic anomaly, is a rare disease with a poor prognosis. Currently, there is no standard treatment due to the poor understanding of KLA. Sirolimus, which is an inhibitor of mammalian target of rapamycin, has been shown to have promising potential in the treatment of complicated vascular anomalies. The aim of this study was to introduce the use of sirolimus for the treatment of KLA and to highlight the challenges of managing this refractory disease. We reported seven patients with KLA who received sirolimus therapy in our center. Combined with previously reported cases, 58.3% achieved a partial response, 25.0% had stable disease, and 16.7% experienced disease progression. No severe sirolimus-related adverse events occurred during treatment. This study suggests that sirolimus is currently an option for the treatment of KLA, and it is hoped that more specific therapies will be developed in the future. Rapid advances in basic science and clinical practice may facilitate the development of important new treatments for KLA.
References
Jul 6, 2004·The Laryngoscope·André-Paul MichaudRichard J H Smith
Apr 24, 2013·Pediatric Blood & Cancer·Israel Fernandez-PinedaGema Lucia Ramirez-Villar
Nov 21, 2013·The Journal of Pediatrics·Stacy E CroteauCameron C Trenor
Oct 14, 2014·Pediatric Blood & Cancer·Violet M FernandesEmily Riehm Meier
Jan 20, 2015·Pediatric Blood & Cancer·Zuopeng WangShan Zheng
Jan 20, 2016·Pediatrics·Denise M AdamsRichard G Azizkhan
Jan 26, 2016·Pediatric Blood & Cancer·Michio OzekiToshiyuki Fukao
Apr 8, 2016·Pediatric Radiology·Pradeep GoyalGulraiz Chaudry
Nov 30, 2016·Pediatric Emergency Care·Manu S RaamMarsha A Elkhunovich
Jan 13, 2017·European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [et Al] = Zeitschrift Für Kinderchirurgie·Carlos ZozayaMiguel Sáenz de Pipaón
May 10, 2017·International Journal of Cancer. Journal International Du Cancer·Yi JiHao Wu
Jul 21, 2017·Pediatric Blood & Cancer·Denise M AdamsCameron C Trenor
Dec 14, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sarah F BarclayKyle C Kurek
Apr 30, 2019·Hematology/oncology Clinics of North America·Denise M Adams, Kiersten W Ricci
May 3, 2019·Pediatric Blood & Cancer·Elisa BoscoloTimothy D Le Cras
Jun 15, 2019·Orphanet Journal of Rare Diseases·Michio OzekiToshiyuki Fukao
Jun 18, 2019·Pediatric Blood & Cancer·Michio OzekiToshiyuki Fukao
Jul 7, 2019·Orphanet Journal of Rare Diseases·Yi JiLi Li
Sep 13, 2019·Orphanet Journal of Rare Diseases·Michio OzekiToshiyuki Fukao
Sep 8, 2020·EMBO Molecular Medicine·Jessica B FosterYoav Dori